{
  "id": "602596691cb411341a0000ad",
  "type": "yesno",
  "question": "Is tofacitinib a JAK inhibitor?",
  "ideal_answer": "Yes, tofacitinib is a small JAK inhibitor.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31721311"
  ],
  "snippets": [
    {
      "text": "The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31721311",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Tofacitinib, a small JAK inhibitor, is approved for the treatment of RA and has demonstrated good efficacy in psoriasis phase III clinical trials. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31721311",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}